Why controversial Implants Approved

On July 28, 2005, the FDA lifted a 13-year ban on silicone-gel breast implants and issued a letter of authority to Mentor Corp authorizing the re-introduction of these controversial implants into the medical market. The move came as Mentor Corp. has urged the FDA that its new silicone inserts are safer and more durable than older versions. The company will only use these plants under the following strict safety conditions approved in accordance with FDA guidelines. - Prospective patients should sign a consent form acknowledging that they are aware of the risks of silicone breast implants, including the fact that they may be broken and need to be replaced or even removed. - Mentor is only allowed to sell silicone breast implants to certified plastic surgeons who are completing a successful effective training program to learn how to insert these implants in a way that reduces the chances of crying and breakage. - The counselor must make and maintain a registry to track the long-term outcomes of patients. - Patients should be educated about the fact that when a tumor breaks down, the effect of occasional fractures does not cause immediate symptoms. In addition, patients are advised to have an MRI five years and two years later to diagnose the fracture. - The counselor must do a 10-year study to determine the percentage of breast implants that will break out immediately. - The implant study should be evaluated by an independent committee. - The FDA will review the results of the Mentor breast implant program within five years to ensure that the plants are working as expected. Based on data from the American Society for Aesthetic Plastic Surgery, 334,052 breast implants were performed in the United States in 2004, mainly using salt-filled plants for sale without restriction. Consumer research predicts that when silicone breast implants return to the market, 200,000 women will visit plastic surgeons to find them in their first year. Concerned with health concerns, silicone plants have a “natural” look and consistency than the saline version, so consumers are preferred. Silicone-gel breast implants were first introduced in 1962 and banned in 1992 amid health fears. Studies since then have shown no statistically significant association between silicone breast tumors and cancer or rare autoimmune diseases such as lupus. A few selected women will swear that their health has deteriorated since they received their implants, however this is rare evidence. When the researchers conducted studies comparing the large group of women with tumors in the same size group without them, no difference between the 2 groups was seen in the number of women with tumors or independent diseases. The most common problem reported is the formation of extra scars around the breast due to an external body reaction. When done locally, it can cause drag and drop effects on the artificial appearance. When red tissue surrounds the implant the condition is called capsular contraction. These scars can form a transplant into an abnormal shape, so that the implant patient appears to have a baseball cap attached to the skin under his chest. This condition is most often caused by the insertion of silicone with smooth walls, although this occurs less frequently with the application of salt once. Plants that are placed behind the chest muscles have a much lower incidence of this problem. Since red tissue is more likely to regenerate, surgeons can always tear the scar tissue by hand. However, this is prohibited by the manufacturer, as it may violate the seal and invalidate the manufacturer's warranty. Generally, patients with a breast transplant contract need follow-up surgery. Surprisingly, the Asthma drug Accolate proved to be helpful in preventing and reversing capsular access, although it may require months of drug treatment. Other possible complications include seroma (serous fluid), hematoma (blood), synmastia (breasts appearing to be centered), drooping (insert slides too far from the chest), duplication (Frame inconsistent) and natural breast rupture), inflation (artificial breaks), tissue necrosis (end of tissue) and infection.